Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials. - Buse,J.B.; Klonoff,D.C.; Nielsen,L.L. (Clin Ther, 2007)